Skip to content
GLP-1 Scorecard
Menu
Graded #208

NextMeds

NextMeds is a cash-pay telehealth platform offering compounded semaglutide and compounded tirzepatide on a flat monthly membership — one price bundling the medication (if prescribed), telehealth visits, a…

Visit NextMedsWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$129/mo (plus a separate fee, compounded)
Tirzepatide
$179/mo (plus a separate fee, compounded)
Coverage
All 50 states
Brand-name
Compounded only

Weigh NextMeds against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because NextMeds dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value55/100
Dose & formulation64/100
Clinical oversight77/100
Labs & monitoring61/100
Fulfillment84/100
Contract terms61/100

Strengths

  • Flat monthly membership bundles the medication, telehealth visits, a 1:1 care coach and a licensed registered dietitian — one price, no hidden fees
  • Same price every dose, no auto-renewal, cancel anytime; free shipping and no insurance needed (FSA eligible)
  • Names a compounding pharmacy partner (Foothills Pharmacy) and states it services all 50 states
  • Free, no-obligation online assessment before you pay anything

Where it loses points

  • Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it
  • Promo-driven pricing with a countdown timer and 'price increases' urgency; the standing membership is $129 (sema) / $179 (tirz)
  • A technology platform that coordinates care, not the medical provider; individual clinicians and a medical director aren't named on the site
  • Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name

Bottom line — Grade C

Best for: Shoppers who want flat-price compounded semaglutide or tirzepatide bundled with a care coach and registered dietitian.

Ranked #208 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest NextMeds — the realistic shortlist.

The 19 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect NextMeds's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on NextMeds's site. Not medical advice; see our disclosure.

← Back to the scorecard